Without looking down, Kira runs her index finger across the screen of an Android tablet that she is holding in her lap. For the occasion, she has painted her fingernails bright pink. When her finger touches a line drawn on the screen, the tablet vibrat…
Month: March 2012
App Turns Tablet Into Math Aid For Visually Impaired Students
Without looking down, Kira runs her index finger across the screen of an Android tablet that she is holding in her lap. For the occasion, she has painted her fingernails bright pink. When her finger touches a line drawn on the screen, the tablet vibrat…
Single Dose of 1% Tropicamide and 10% Phenylephrine for Pupillary Dilation
Status: Completed,
Condition Summary: Eye Diseases
Gene Therapy in Ophthalmology Update 9: Oxford BioMedica/OHSU Preparing to Treat First Usher Syndrome Patient & Oxford BioMedica Ophthalmic Program Update
In an announcement today from the Foundation Fighting Blindness, and confirmed by Oxford BioMedica, the Casey Eye Institute of the Oregan Health & Science University (OHSU) is preparing to treat the first Usher Syndrome patient under the clinical p…
An Infant With Leukocoria
What condition do you suspect is present in this 4-week-old infant with bilateral leukocoria? Medscape Ophthalmology
Ivantis initiates enrollment in Hydrus Microstent study for open angle glaucoma
Ivantis announced the enrollment of the first patient in the Hydrus IV study today. The Hydrus Microstent is the world’s first intracanalicular scaffold for treatment of primary open angle glaucoma, a disease that afflicts over 70 million people worldw…
UC Davis develops new sensor for use in medical applications
A new kind of flexible, transparent pressure sensor, developed at the University of California, Davis, for use in medical applications, relies on a drop of liquid.
Scientists successfully cultivate stem cells on human corneas
A new cornea may be the only way to prevent a patient going blind – but there is a shortage of donated corneas and the queue for transplantation is long. Scientists at the Sahlgrenska Academy at the University of Gothenburg, Sweden, have for the first …
Public Health Interventions for Asthma, An Umbrella Review, 1990–2010
By: Asthma2012
ACADIA, Allergan extend drug discovery collaboration
ACADIA Pharmaceuticals Inc., a biopharmaceutical company focused on innovative treatments that address unmet medical needs in neurological and related central nervous system disorders, today announced that it has extended its drug discovery and develop…
American Glaucoma Society 22nd Annual Meeting
Read clinically focused news coverage of key developments from the meeting. Medscape Ophthalmology
Hungry People See Food-Related Words More Clearly
Our senses aren’t just delivering a strict view of what’s going on in the world; they’re affected by what’s going on in our heads. A new study finds that hungry people see food-related words more clearly than people who’ve just eaten…
AMD Update 18: A New Approach to Fighting Retinal Degeneration
I just learned this afternoon, of a start-up company, MitoChem Therapeutics, which is apparently an outgrowth of the Vision Research program at the Ophthalmology department at the University of South Carolina. Two of their scientists, Drs. Rohrer and B…
Smartphones and Other Gadgets Help Low Vision
New gadgets can help with the shifting needs of patients with low vision, experts say. Medscape Medical News
“Preservative Toxicity a Disease,” Reports Working Group on Glaucoma Medication Preservatives Toxicity
Valeant Ophthalmics, a division of Valeant Pharmaceuticals North America LLC, announced that the Working Group on Preservatives Toxicity in Glaucoma Medications, an advisory panel of glaucoma treatment experts, was recently convened as an ongoing group…
Clinical Negligence in Ophthalmology: Fifteen Years of National Health Service Litigation Authority Data
Objective:
To categorize and understand the reasons behind ophthalmic clinical negligence claims in the National Health Service and how such claims can be avoided.
Design:
Retrospective analyses of all ophthalmic clinical negligence claims between …
Iluvien Update 5: European Approval on the Horizon
Finally, some good news for Alimera (and pSivida). A few days ago, the company announced that it had received a positive outcome to the Decentralized Procedure (DCP) for Iluvien in Europe. Iluvien is now expected to be the first sustained release pharm…
Photon etc. announces the launch of IRIS, an innovative Retinal Hyperspectral Imaging system
Targeting the emergent field of hyperspectral retinal imaging, Photon etc. is proud to launch IRIS™, a new device for non-invasive localization of biomolecules in the eye fundus. Based on a custom-made mydriatic retinal camera and Photon etc.’s Tun…
How does nearsightedness develop in children?
Myopia (nearsightedness) develops in children when the lens stops compensating for continued growth of the eye, according to a new study.
Iluvien Marches Forward in Europe
Iluvien, a sustained drug delivery system for the treatment of diabetic macular edema, gets closer to medical use in Europe. This novel treatment for DME remains viable.